<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01451983</url>
  </required_header>
  <id_info>
    <org_study_id>CCF 09-624</org_study_id>
    <secondary_id>UL1RR024989</secondary_id>
    <nct_id>NCT01451983</nct_id>
  </id_info>
  <brief_title>Genetics, Brain Structure and Thinking Skills in Autism</brief_title>
  <official_title>Genetic, Biochemical, Behavioral and Neuroimaging Phenotypes of Autism Spectrum Disorders (ASDs)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Center for Research Resources (NCRR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to better understand the genetic, biochemical, cognitive and
      behavioral symptom abnormalities that contribute to autism spectrum disorders. The
      investigators anticipate recruiting at least 100 participants with autism spectrum disorder
      and large head size, at least 100 participants with autism spectrum disorder without large
      head size and at least 40 healthy siblings. Biological parents are expected to be recruited
      only as genetic changes are identified in individuals with autism spectrum disorders to
      better understand the nature of these genetic changes. Participants are asked to complete
      cognitive testing, a blood draw, urine collection and measurement of his/her height, weight
      and head circumference. Parents or caregivers may be asked to complete a diagnostic
      evaluation and will complete questionnaires that examine the participant's medical and family
      history as well as his/her current symptoms, functioning, and quality of life. A brief report
      simply listing and giving a basic description of any behavioral diagnostic information,
      autism symptoms, adaptive functioning, and a listing of results from cognitive testing will
      be provided as part of this study.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Total Brain Volume</measure>
    <time_frame>Baseline</time_frame>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">138</enrollment>
  <condition>Autism Spectrum Disorders</condition>
  <arm_group>
    <arm_group_label>ASD with PTEN</arm_group_label>
    <description>Individuals with autism spectrum disorder who are also found to have a PTEN mutation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ASD no PTEN macrocephaly</arm_group_label>
    <description>Individuals with autism spectrum disorder who do not have a PTEN mutation with a large head circumference.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ASD no PTEN no macrocephaly</arm_group_label>
    <description>Individuals with autism spectrum disorder who do not have a PTEN mutation without a large head circumference.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Siblings</arm_group_label>
    <description>Siblings of individuals with autism spectrum disorders.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      About 6 tubes of blood or up to 50 ml (3-4 tablespoons) and 30 mL of urine will be collected.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        We anticipate recruiting 80 participants with autism spectrum disorder and large head size,
        80 participants with autism spectrum disorder without large head size and 40 healthy
        siblings. Biological parents are expected to be recruited only as genetic changes are
        identified in individuals with autism spectrum disorders to better understand the nature of
        these genetic changes.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of autism

          -  Consent from parents or guardians or an adult with or suspected of having an autism
             spectrum disorder that does not require a legal guardian or an adult who is the
             healthy sibling of an individual with an autism spectrum disorder.

          -  Youth ages 2-17 and adults ages 18-50. Youths and adults who are able (some young or
             severely impaired participants may not be able to provide assent) will be asked to
             provide assent.

          -  Families with multiple children who meet the above inclusion criteria will be
             permitted to have as many children participate as they wish.

          -  Youth ages 2-17 and adults ages 18-50 who do not have an autism spectrum disorder or
             are not suspected of having an autism spectrum disorder and who have a sibling with an
             autism spectrum disorder who has participated in the present study.

        Exclusion Criteria:

          -  Clinically significant medical disease that would prohibit participation in the study
             procedures.

          -  Children younger than 2 years old and adults older than 50 years old.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas W Frazier, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Charis Eng, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cleveland Clinic Center for Autism</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://clevelandclinic.org/autismresearch</url>
    <description>Cleveland Clinic Center for Autism Research Website</description>
  </link>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 11, 2011</study_first_submitted>
  <study_first_submitted_qc>October 13, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 14, 2011</study_first_posted>
  <results_first_submitted>December 12, 2014</results_first_submitted>
  <results_first_submitted_qc>January 7, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 14, 2015</results_first_posted>
  <last_update_submitted>January 7, 2015</last_update_submitted>
  <last_update_submitted_qc>January 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Cleveland Clinic</investigator_affiliation>
    <investigator_full_name>Thomas W. Frazier, Ph.D</investigator_full_name>
    <investigator_title>Autism Research Program Director</investigator_title>
  </responsible_party>
  <keyword>Autism</keyword>
  <keyword>PTEN</keyword>
  <keyword>macrocephaly</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Autistic Disorder</mesh_term>
    <mesh_term>Autism Spectrum Disorder</mesh_term>
    <mesh_term>Child Development Disorders, Pervasive</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>ASD With PTEN</title>
          <description>Individuals with autism spectrum disorder who are also found to have a PTEN mutation.</description>
        </group>
        <group group_id="P2">
          <title>ASD no PTEN Macrocephaly</title>
          <description>Individuals with autism spectrum disorder who do not have a PTEN mutation with a large head circumference.</description>
        </group>
        <group group_id="P3">
          <title>ASD no PTEN no Macrocephaly</title>
          <description>Individuals with autism spectrum disorder who do not have a PTEN mutation without a large head circumference.</description>
        </group>
        <group group_id="P4">
          <title>Siblings</title>
          <description>Siblings of individuals with autism spectrum disorders.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="27"/>
                <participants group_id="P3" count="61"/>
                <participants group_id="P4" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="27"/>
                <participants group_id="P3" count="61"/>
                <participants group_id="P4" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>ASD With PTEN</title>
          <description>Individuals with autism spectrum disorder who are also found to have a PTEN mutation.</description>
        </group>
        <group group_id="B2">
          <title>ASD no PTEN Macrocephaly</title>
          <description>Individuals with autism spectrum disorder who do not have a PTEN mutation with a large head circumference.</description>
        </group>
        <group group_id="B3">
          <title>ASD no PTEN no Macrocephaly</title>
          <description>Individuals with autism spectrum disorder who do not have a PTEN mutation without a large head circumference.</description>
        </group>
        <group group_id="B4">
          <title>Siblings</title>
          <description>Siblings of individuals with autism spectrum disorders.</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="26"/>
            <count group_id="B2" value="27"/>
            <count group_id="B3" value="61"/>
            <count group_id="B4" value="24"/>
            <count group_id="B5" value="138"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11.9" lower_limit="2" upper_limit="34"/>
                    <measurement group_id="B2" value="13.3" lower_limit="2" upper_limit="38"/>
                    <measurement group_id="B3" value="9.0" lower_limit="2" upper_limit="45"/>
                    <measurement group_id="B4" value="11.7" lower_limit="2" upper_limit="36"/>
                    <measurement group_id="B5" value="11.4" lower_limit="2" upper_limit="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="53"/>
                    <measurement group_id="B4" value="14"/>
                    <measurement group_id="B5" value="108"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Total Brain Volume</title>
        <time_frame>Baseline</time_frame>
        <population>MRI acquisition was performed using Siemens Q4 TIM Trio 3 tesla scanner with standard 12-channel receive-only head coil. An 8-minute whole-brain T1-weighted inversion recovery turboflash (MPRAGE) was acquired. Volumetric measurements were obtained using the software suite Freesurfer. Not all participants received imaging due to age and impairment.</population>
        <group_list>
          <group group_id="O1">
            <title>ASD With PTEN</title>
            <description>Individuals with autism spectrum disorder who are also found to have a PTEN mutation.</description>
          </group>
          <group group_id="O2">
            <title>ASD no PTEN Macrocephaly</title>
            <description>Individuals with autism spectrum disorder who do not have a PTEN mutation with a large head circumference.</description>
          </group>
          <group group_id="O3">
            <title>ASD no PTEN no Macrocephaly</title>
            <description>Individuals with autism spectrum disorder who do not have a PTEN mutation without a large head circumference.</description>
          </group>
          <group group_id="O4">
            <title>Siblings</title>
            <description>Siblings of individuals with autism spectrum disorders.</description>
          </group>
        </group_list>
        <measure>
          <title>Total Brain Volume</title>
          <population>MRI acquisition was performed using Siemens Q4 TIM Trio 3 tesla scanner with standard 12-channel receive-only head coil. An 8-minute whole-brain T1-weighted inversion recovery turboflash (MPRAGE) was acquired. Volumetric measurements were obtained using the software suite Freesurfer. Not all participants received imaging due to age and impairment.</population>
          <units>cubic centimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="16"/>
                <count group_id="O3" value="38"/>
                <count group_id="O4" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1634.1" spread="272.6"/>
                    <measurement group_id="O2" value="1409.8" spread="158.6"/>
                    <measurement group_id="O3" value="1236.7" spread="121.3"/>
                    <measurement group_id="O4" value="1401.9" spread="199.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>4 years 3 months from May 2010- August 2014</time_frame>
      <group_list>
        <group group_id="E1">
          <title>ASD With PTEN</title>
          <description>Individuals with autism spectrum disorder who are also found to have a PTEN mutation.</description>
        </group>
        <group group_id="E2">
          <title>ASD no PTEN Macrocephaly</title>
          <description>Individuals with autism spectrum disorder who do not have a PTEN mutation with a large head circumference.</description>
        </group>
        <group group_id="E3">
          <title>ASD no PTEN no Macrocephaly</title>
          <description>Individuals with autism spectrum disorder who do not have a PTEN mutation without a large head circumference.</description>
        </group>
        <group group_id="E4">
          <title>Siblings</title>
          <description>Siblings of individuals with autism spectrum disorders.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="61"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Modest PTEN-ASD sample size and difficulty in closely matching each PTEN patient to one or more patients from each comparison group; Lack of comprehensively characterized PHTS patients without ASD is also a limitation.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Thomas W. Frazier, PhD</name_or_title>
      <organization>Cleveland Clinic Center for Autism</organization>
      <phone>216-448-6440</phone>
      <email>fraziet2@ccf.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

